Avalon Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.5K | Sell |
350
-536
| -60% | -$37.5K | ﹤0.01% | 312 |
|
|
2025
Q1 | $65.1K | Buy |
886
+536
| +153% | +$39.4K | 0.01% | 219 |
|
|
2024
Q4 | $22.9K | Sell |
350
-1,200
| -77% | -$78.6K | ﹤0.01% | 286 |
|
|
2024
Q3 | $121K | Sell |
1,550
-1,200
| -44% | -$93.5K | 0.01% | 152 |
|
|
2024
Q2 | $214K | Hold |
2,750
| – | – | 0.02% | 124 |
|
|
2024
Q1 | $186K | Sell |
2,750
-800
| -23% | -$54.2K | 0.02% | 137 |
|
|
2023
Q4 | $239K | Sell |
3,550
-175
| -5% | -$11.8K | 0.02% | 114 |
|
|
2023
Q3 | $252K | Hold |
3,725
| – | – | 0.03% | 104 |
|
|
2023
Q2 | $267K | Hold |
3,725
| – | – | 0.02% | 112 |
|
|
2023
Q1 | $259K | Buy |
+3,725
| New | +$259K | 0.03% | 109 |
|